SCHEMBL4247285

SCHEMBL4247285

C=CCc1cc(C(N)=O)ccc1O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.58
ALDH1A1 P00352 2/20 0.58
HPGD P15428 2/20 0.58
LMNA P02545 1/20 0.58
GABRA1 P14867 2/20 0.58
GABRB2 P47870 2/20 0.58
POLB P06746 2/20 0.54
MEN1 O00255 1/20 0.46
ALOX5 P09917 1/20 0.46
GAA P10253 1/20 0.46
MAPT P10636 1/20 0.46
GABRB1 P18505 1/20 0.46
RXRA P19793 1/20 0.46
CNR1 P21554 1/20 0.46
GABRA5 P31644 1/20 0.46
GABRA3 P34903 1/20 0.46
CNR2 P34972 1/20 0.46
GABRA2 P47869 1/20 0.46
KMT2A Q03164 1/20 0.46
ACE2 Q9BYF1 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8465492 0.86 HTT (0.61) HTTALDH1A1HPGDLMNAGABRA1
SCHEMBL4943834 0.86 HTT (0.61) HTTALDH1A1HPGDLMNAGABRA1
SCHEMBL13636371 0.85 HPGD (0.43) HTTALDH1A1HPGDLMNAGABRA1
SCHEMBL9550443 0.84 HTT (0.60) HTTALDH1A1HPGDLMNAGABRA1
SCHEMBL1092424 0.83 HTT (0.71) HTTALDH1A1HPGDLMNAGABRA1
SCHEMBL7105508 0.83 ALDH1A1 (0.41) HTTALDH1A1HPGDLMNAGABRA1
SCHEMBL9349415 0.81 HTT (0.57) HTTALDH1A1HPGDLMNAGABRA1
Zinc Ion SCHEMBL9550437 0.81 HTT (0.57) HTTALDH1A1HPGDLMNAGABRA1
SCHEMBL10710591 0.80 ALDH1A1 (0.41) HTTALDH1A1HPGDLMNAGABRA1
SCHEMBL20402834 0.80 HTT (0.77) HTTALDH1A1HPGDPOLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2081891-A2 PHARMACEUTICAL COMPOUNDS HAVING HSP90 INHIBITORY OR MODULATING ACTIVITY Astex Therapeutics Limited (GB) 2009-07-29 EP disclosed
EP-2073802-A1 PHARMACEUTICAL COMBINATIONS Astex Therapeutics Limited (GB) 2009-07-01 EP disclosed
EP-2073803-A1 PHARMACEUTICAL COMBINATIONS Astex Therapeutics Limited (GB) 2009-07-01 EP disclosed
EP-2073807-A1 PHARMACEUTICAL COMBINATIONS Astex Therapeutics Limited (GB) 2009-07-01 EP disclosed
WO-2008044045-A1 PHARMACEUTICAL COMBINATIONS ASTEX THERAPEUTICS LIMITED (GB) 2008-04-17 WO disclosed
WO-2008044029-A1 PHARMACEUTICAL COMBINATIONS ASTEX THERAPEUTICS LIMITED (GB) 2008-04-17 WO disclosed
WO-2008044041-A1 PHARMACEUTICAL COMBINATIONS ASTEX THERAPEUTICS LIMITED (GB) 2008-04-17 WO disclosed
WO-2008044027-A2 PHARMACEUTICAL COMPOUNDS HAVING HSP90 INHIBITORY OR MODULATING ACTIVITY ASTEX THERAPEUTICS LIMITED (GB) 2008-04-17 WO disclosed
EP-1883402-A2 HYDROXYBENZAMIDE DERIVATIVES AND THEIR USE AS INHIBITORS OF HSP90 Astex Therapeutics Limited (GB) 2008-02-06 EP disclosed
EP-1877379-A1 HYDROXYBENZAMIDE DERIVATIVES AND THEIR USE AS INHIBITORS OF HSP90 Astex Therapeutics Limited (GB) 2008-01-16 EP disclosed
WO-2006109075-A2 HYDROXYBENZAMIDE DERIVATIVES AND THEIR USE AS INHIBITORS OF HSP90 ASTEX THERAPEUTICS LIMITED (GB) 2006-10-19 WO disclosed
WO-2006109085-A1 HYDROXYBENZAMIDE DERIVATIVES AND THEIR USE AS INHIBITORS OF HSP90 ASTEX THERAPEUTICS LIMITED (GB) 2006-10-19 WO disclosed